Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to... see more

TSXV:SBM - Post Discussion

Sirona Biochem Corp > is it possible R+F is waiting for
View:
Post by Mickey2 on Oct 26, 2020 6:18am

is it possible R+F is waiting for

is it possible R+F is waiting for the 0.4% TFC-1067 clinical trial to be completed.  Perhaps R+F wishes to use the 0.4% for faster more efficacy.
I think we have a winner here.

Thoughts anyone?
Comment by forhandlaren on Oct 26, 2020 7:03am
Unlikely, R+F is selling cosmetics. The 0.4 concentration will probably require a prescription, hence the study collaboration with a pharmaceutical company. 
Comment by wexworth on Oct 26, 2020 7:46am
that question was asked several times, and no, the .2% is the product Rodan are going for in terms of their line up.
Comment by JohnFriesen on Oct 26, 2020 8:33am
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities